These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 15265259)

  • 21. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany.
    Diener HC; Gendolla A
    Curr Med Res Opin; 2005; 21 Suppl 3():S18-24. PubMed ID: 16083520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ; Yates R
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine is associated with menorrhagia and endometriosis.
    Tietjen GE; Conway A; Utley C; Gunning WT; Herial NA
    Headache; 2006 Mar; 46(3):422-8. PubMed ID: 16618258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence and impact of migraine on US Military officer trainees.
    Helseth EK; Erickson JC
    Headache; 2008 Jun; 48(6):883-9. PubMed ID: 18005047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.
    Klapper J; Lucas C; Røsjø Ø; Charlesworth B;
    Cephalalgia; 2004 Nov; 24(11):918-24. PubMed ID: 15482352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ; Charlesworth BR
    Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
    Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M
    Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression and anxiety: effect on the migraine-obesity relationship.
    Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA
    Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
    Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
    Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.
    Lambert J; Carides GW; Meloche JP; Gerth WC; Marentette MA
    Can J Clin Pharmacol; 2002; 9(3):158-64. PubMed ID: 12422253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura.
    D'Amico D; Grazzi L; Usai S; Rigamonti A; Curone M; Bussone G
    Headache; 2005 May; 45(5):553-60. PubMed ID: 15953274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.
    Linde M; Dahlöf C
    Cephalalgia; 2004 Jun; 24(6):455-65. PubMed ID: 15154855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of headache in a population of health care workers and the effects on productivity costs.
    Cristofolini A; Dalla Serra P; Scherillo G; Orrico D; Micciolo R
    Med Lav; 2008; 99(1):8-15. PubMed ID: 18254535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.